tiprankstipranks
Trending News
More News >
Genomma Lab Internacional SAB de CV Class B (GNMLF)
OTHER OTC:GNMLF
US Market
Advertisement

Genomma Lab Internacional SAB de CV (GNMLF) Financial Statements

Compare
16 Followers

Genomma Lab Internacional SAB de CV Financial Overview

Genomma Lab Internacional SAB de CV's market cap is currently $949.79M. The company's EPS TTM is $0.033996689999999996; its P/E ratio is 10.84; and it has a dividend yield of 3.85%. Genomma Lab Internacional SAB de CV is scheduled to report earnings on October 23, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Genomma Lab Internacional SAB de CV Earnings and Revenue History

Genomma Lab Internacional SAB de CV Debt to Assets

Genomma Lab Internacional SAB de CV Cash Flow

Genomma Lab Internacional SAB de CV Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis